Juvenile idiopathic arthritis (JIA) encompasses a group of pediatric inflammatory arthritides that includes oligoarticular JIA, polyarticular JIA, systemic JIA, psoriatic JIA, and enthesitis-related ...

Arthritis is a disorder that affects areas in which two bones join together, like joints, which causes pain, stiffness, and swelling. This leads to limited movement and pain for many. By learning ...

Please provide your email address to receive an email when new articles are posted on . Kevzara is approved for polyarticular JIA in patients weighing 63 kg or greater. The drug is an IL-6 inhibitor ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Understanding the subtypes of juvenile idiopathic arthritis can help adult and pediatric ...

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease affecting children. A significant complication of JIA is involvement of the temporomandibular joint (TMJ), where ...

UK scientists have explored the role of B cells and T cells in the development of uveitis among patients with juvenile idiopathic arthritis ...

Arthritis is not just an old person's disease. Children can get arthritis too, and some forms can be deadly. July is Juvenile Arthritis Awareness Month. A local boy is doing what he can to spread ...

Relapse occurred in over half of patients with juvenile idiopathic arthritis (JIA) within a year of stopping biologic or targeted synthetic disease-modifying antirheumatic drug (DMARD) treatment after ...

NEW YORK--(BUSINESS WIRE)--PIF Partners announced today that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to its proprietary investigational ...

Juvenile idiopathic arthritis (JIA) encompasses a heterogeneous group of chronic inflammatory arthritides that manifest before the age of 16. Despite its uncertain aetiology, research has increasingly ...